Skip to content

Biomarkers of Acute Kidney Injury in Cardiac Surgery

Biomarkers in Estimation for Risk of Acute Kidney Injury in Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03830450
Acronym
AKIrisk
Enrollment
50
Registered
2019-02-05
Start date
2020-12-01
Completion date
2022-12-31
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury (Nontraumatic)

Keywords

Acute kidney injury, Cardiac surgery, NGAL, GDF-15

Brief summary

Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI risk. Because of that, today different biomarkers are investigated to predict incidence for development AKI after cardiac surgery. This investigation will try to find potentially risk patients for developing AKI after cardiac surgery by using conventional markers (creatinine, glomerular filtration rate) in perioperative period comparing with two different biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and growth differentiation factor 15 (GDF-15) which are proven markers in patients with increased risk for AKI development.

Interventions

None listed

Sponsors

Nikola Bradic, MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* patients scheduled for cardiac surgery (CABG, valve replacement/repair, combined) * older than 18 years

Exclusion criteria

* previous known renal disease * patients on chronic dialysis

Design outcomes

Primary

MeasureTime frameDescription
Consecutive values of neutrophil gelatinase-associated lipocalin (NGAL)One yearBy the changing of NGAL values in consecutive measuring, predict which patients are in increased risk for development of AKI
Consecutive values of growth differentiation factor 15 (GDF-15)One yearBy the changing of GDF-15 values in consecutive measuring, predict which patients are in increased risk for development of AKI
Consecutive values of glomerular filtration rate (GFR)One YearBy the changing of GFR values in consecutive measuring, predict which patients are in increased risk for development of AKI

Contacts

Primary ContactNikola Bradic, MD
nbradic@kbd.hr+385 91 589 3480

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026